The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Accelerated Amyloid Deposition in the Brains of Transgenic Mice Coexpressing Mutant Presenilin 1 and Amyloid Precursor Proteins
Open accessAbstract
Missense mutations in two related genes, termed presenilin 1 (PS1) and presenilin 2 (PS2), cause dementia in a subset of early-onset familial Alzheimer's disease (FAD) pedigrees. In a variety of experimental in vitro and in vivo settings, FAD-linked presenilin variants influence the processing of the amyloid precursor protein (APP), leading to elevated levels of the highly fibrillogenic Abeta1-42 peptides that are preferentially deposited in the brains of Alzheimer Disease (AD) patients. In this report, we demonstrate that transgenic animals that coexpress a FAD-linked human PS1 variant (A246E) and a chimeric mouse/human APP harboring mutations linked to Swedish FAD kindreds (APP swe) develop numerous amyloid deposits much earlier than age-matched mice expressing APP swe and wild-type Hu PS1 or APP swe alone. These results provide evidence for the view that one pathogenic mechanism by which FAD-linked mutant PS1 causes AD is to accelerate the rate of beta-amyloid deposition in brain.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, APP mice develop dystrophic neurites immediately around plaques (50), suggesting that this neuronal pathology is independent of cell death.”
From Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice (2013) · cites this paper as [50]
In the citing paper
“However, such studies have not definitively identified which Aβ species are responsible for seeding amyloid deposition in either the parenchyma or vasculature.”
From Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice (2005) · cites this paper as Borchelt et al., 1997
In the citing paper
“Increasing relative Aβ42 levels lowers the age when deposition first occurs, increases the amount of diffuse Aβ, and promotes parenchymal versus cerebrovascular deposition.”
From Aβ42 Is Essential for Parenchymal and Vascular Amyloid Deposition in Mice (2005) · cites this paper as Borchelt et al., 1997
In the citing paper
“These genetic findings led to several transgenic mouse models that successfully recapitulated Aβ plaque formation, increasing support for the hypothesis (Table 1) [23–29].”
From Systems-based proteomics to resolve the biology of Alzheimer’s disease beyond amyloid and tau (2021) · cites this paper as [24]
Citations
Cites
1 retracted
Familial Alzheimer's disease associated with S182 codon 286 mutation
Chapman, J., Asherov, A., Wang, N., Treves, T. A., Korczyn, A. D., & Goldfarb, L. G. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91723-3 · Cited by 25
RetractedMcKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Self-citationGoate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210
Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease
Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051
Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599
Candidate gene for the chromosome 1 familial Alzheimer’s disease locus
Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577
Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein
Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516
Self-citationRogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., et al. (1995) · Nature · doi:10.1038/376775a0 · Cited by 2,052
Jarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022
Research works printed but not linked: 2
- Barelli, 1997, Characterization of new polyclonal antibodies specific for 40 and 42 amino acid-long amyloid β peptides, Mol. Med, in press
- Kim, 1990, Detection and quantitation of amyloid β-peptide with 2 monoclonal antibodies, Neurosci. Res. Commun, 7, 113
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Physiologic and Neurotoxic Properties of Aβ Peptides
Gregory, G. C., Shepherd, C. E., & Halliday, G. M. (2006) · Springer eBooks · doi:10.1007/978-1-84628-440-3_11 · Cited by 1
Genetically Engineered Mouse Models of Neurodegenerative Disorders
Masliah, E., & Crews, L. A. (2007) · Springer eBooks · doi:10.1007/0-387-25919-8_19 · Cited by 1
The Value of Transgenic Models for the Study of Neurodegenerative Diseases
Price, D. L., Wong, P. C., Markowska, A. L., Thinakaran, G., Lee, M. K., Martin, L. J., Rothstein, J. D., Sisodia, S. S., & Borchelt, D. (2001) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-662-04399-8_5 · Cited by 1
Self-citationIkezu, T. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_30 · Cited by 1
Leighty, R. E. (2009) · Digital Commons - University of South Florida (University of South Florida) · Cited by 1
Proteolysis in Neurodegenerative Diseases
HOOK, V. Y. H., & Mende‐Mueller, L. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-006-3_5 · Cited by 1
The aging synapse: Synaptic proteome changes in mouse models of aging
Végh, M. J. (2012) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) · Cited by 1
Emerging strategies for the treatment of Alzheimer’s disease at the Millennium
Emmerling, M. R., Spiegel, K., Hall, E. D., LeVine, H., Walker, L. C., Schwarz, R. D., & Gracon, S. I. (1999) · Emerging Drugs · doi:10.1517/14728214.4.1.35 · Cited by 1
Pathogenesis and Mechanism of Cerebral Amyloidosis in APP Transgenic Mice
Jucker, M., Calhoun, M. E., Phinney, A. L., Stalder, M., Bondolfi, L., Winkler, D. T., Herzig, M. C., Pfeifer, M., Boncristiano, S., Tolnay, M., et al. (2001) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-662-04399-8_6 · Cited by 1
Genetically Engineered Models of Human Age-Related Neurodegenerative Diseases
Vickers, J. C. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50027-5 · Cited by 1
Biological activities of amyloid precursor protein
Gulya, K. (1998) · Acta Biologica Hungarica · doi:10.1007/bf03542974 · Cited by 1
Presenilin-Based Transgenic Models of Alzheimer’s Dementia
Yoshiike, Y., & Takashima, A. (2010) · Neuromethods · doi:10.1007/978-1-60761-898-0_21 · Cited by 1
Synaptic modifications in hippocampal CA3 pyramidal cells in an Alzheimer's mouse model
Zhang, P. (2018) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-6752 · Cited by 1
Rejc, L., Gómez‐Vallejo, V., Ríos, X., Cossío, U., Baz, Z., Mujica, E., Gião, T., Cotrina, E. Y., Jiménez‐Barbero, J., Quintana, J. R., et al. (2020) · doi:10.21203/rs.2.23011/v1 · Cited by 1
Wang, J., Hecimovic, S. K., & Goate, A. (2006) · Wiley-VCH eBooks · doi:10.1002/3527600906.mcb.200300078 · Cited by 1
Analysis of Reelin function in the molecular mechanisms underlying Alzheimer’s disease
Rossi, D. P. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Portugal, C. C., Santos, E. C. D. S., Pacheco, A. M., Pinto, S., Almeida, T. O., Tedim-Moreira, J., Gavin, D., Canedo, T., de Oliveira, F. S., Summavielle, T., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.29.582679 · Cited by 1
Targeting Early Stages of Alzheimer’s Disease in a Transgenic Model
Lord, A. (2009) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Molecular Genetics and Molecular Biology of Alzheimer’s Disease
Sandbrink, R., & Beyreuther, K. T. (2001) · Springer eBooks · doi:10.1007/978-3-642-59519-6_72
Effec ts of hyperoxia in alzheimers transgenic mice
Cox, A. (2005) · Digital Commons - University of South Florida (University of South Florida)
Brain sterol metabolism : modulating Alzheimer’s disease
Vanmierlo, T. (2010) · Research Publications (Maastricht University) · doi:10.26481/dis.20100930tv
INCREASED OXIDATIVE DAMAGE TO DNA AND THE EFFECTS ON MITOCHONDRIAL PROTEIN IN ALZHEIMER'S DISEASE
Wang, J. (2006) · UKnowledge (University of Kentucky)
Muthuswamy, A. (2008) · UKnowledge (University of Kentucky)
Transgenic Mice Model in Alzheimer's Disease
Duan, X., & Y., G. (2002) · Hong Kong journal of psychiatry
Multilingualism and the risk of Alzheimer disease and dementia
Hack, E. E. (2011) · UWSpace (University of Waterloo)
Cracchiolo, J. R. (2005) · Digital Commons - University of South Florida (University of South Florida)
Studies on -secretase activity and products
Frånberg, J. (2010) · Figshare
Gururaj Joshi, A. (2006) · UKnowledge (University of Kentucky)
Shippy, D. C. (2005) · Digital Commons - University of South Florida (University of South Florida)
Jonghe, C. D., & Broeckhoven, C. V. (1999) · Techniques in the behavioral and neural sciences · doi:10.1016/s0921-0709(99)80063-7
Neural stem cell biology and neurogenesis in mouse models of aging and Alzheimer's disease
Ermini, F. (2006) · edoc (University of Basel) · doi:10.5451/unibas-003819315
Mechanisms of Brain Region-Specific Amyloid-beta Deposition
Bero, A. W. (2011) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7cj8bh2
Stimulating Neuroprotective and Regenerative Mechanisms in Alzheimer Disease
Lilja, A. M. (2013) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.8515
Effects of long-term administration of caffeine in a mouse model for Alzheimer's disease
Schleif, W. S. (2005) · Digital Commons - University of South Florida (University of South Florida)
ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR REGULATION IN EXPERIMENTAL NEURODEGENERATIVE DISEASE
Charriez, C. M. (2010) · UKnowledge (University of Kentucky)
β-secretase: Physiological Role and Target Validation
Laird, F. M., Farah, M. H., Lee, H., Savonenko, A. V., Price, D. L., & Wong, P. C. (2007) · Springer eBooks · doi:10.1007/978-0-387-35135-3_4
Self-citationDevelopment and Applications of Transgenics in Biotechnology and Medicine
dos Santos, W. G., & Fillmore, H. L. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-532-9_7
Tiermodelle in der biomedizinischen Forschung
Britsch, S., Strehle, M., & Birchmeier, C. (2003) · Springer eBooks · doi:10.1007/978-3-662-07588-3_10
A Training Program in Breast Cancer Research Using NMR Techniques
Wang, P. C. (2001) · Defense Technical Information Center (DTIC) · doi:10.21236/ada396802
Transgenic Models of Amyotrophic Lateral Sclerosis and Alzheimer's Disease
Wong, P. C., Borchelt, D., Lee, M. K., Thinakaran, G., Sisodia, S. S., & Price, D. L. (1998) · Elsevier eBooks · doi:10.1016/b978-012734610-6/50008-7
Self-citationTransgenic Approaches to the Study of Alzheimer’s Disease
Duff, K. (1998) · Springer eBooks · doi:10.1007/978-3-642-72103-8_11
Hall, K. (2011) · ORCA Online Research @Cardiff (Cardiff University)
Pathogenesis of Alzheimer's Dementia
Suh, Y. (2006) · Journal of the Korean Medical Association · doi:10.5124/jkma.2006.49.8.717
Animal models of Alzheimer’s disease for preclinical research
Takahashi, H. (2010) · Folia Pharmacologica Japonica · doi:10.1254/fpj.136.6
Role for the Peripheral Benzodiazepine Receptor in Neuroinflammation of Neurodegenerative disorders
Venneti, S. (2006) · D-Scholarship@Pitt (University of Pittsburgh)
From Poe to Roe: a Bickelian view of the abortion decision--its timing and principle.
Polityka, T. (1974) · PubMed
Tran, H. (2011) · Open Scholarship Institutional Repository (Washington University in St. Louis) · doi:10.7936/k7gb223z
Proteolysis of Mutant Gene Products are Key Mechanisms in Neurodegenerative Diseases
HOOK, V. Y. H. (2002) · Springer eBooks · doi:10.1007/0-306-46847-6_17
Balthazar, J. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2013.tde-26092013-111146
Magnetic resonance studies in Alzheimer´s disease
Westman, E. (2009) · Figshare
On nogo receptors, plasticity and lasting memories
Karlsson, T. E. (2012) · Figshare
Genetic and Expressional Studies of Alzheimer's Disease
Iivonen, S. (2005)
Transgenic Mice Overexpressing Presenilin cDNAs
Duff, K. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-691-1_7
Imaging mouse models of neurodegeneration using multi-parametric MRI
Holmes, H. (2015) · UCL Discovery (University College London)
Price, D. L., Savonenko, A. V., Li, T., & Wong, P. C. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9780511980053.009
Self-citationdouble mutant knock-in mice model of Alzheimer disease as a function of age
Rukhsana Sultana, A., Abdul, H. M., Markesbery, W. R., Cai, J., Pierce, W. M. J., & Allan, D. (2011)
Luo, Y. (2008) · Oxidative stress and disease · doi:10.1201/9780849381492.ch18
Amyloid- _ Peptide, a Therapeutic Target for Alzheimer’s Disease?
Luo, Y., & Butko, P. (2005) · Oxidative stress and disease · doi:10.1201/9781420026559.ch23
Assays for Amyloid Precursor Protein γ-Secretase Activity
Xia, W., Wolfe, M. S., & Campbell, W. A. (2004) · CRC Press eBooks · doi:10.1201/9780203492185.ch5
Model Organisms and Neurogenetics
Krantz, D. E., & Jackson, G. R. (2007) · Medical psychiatry · doi:10.3109/9781420019544.006
Princz-Kranz, F. L. (2010) · Zurich Open Repository and Archive (University of Zurich) · doi:10.3929/ethz-a-006097535
Kurdakova, A. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5882
Rudinskiy, N., & Spires‐Jones, T. L. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-394431-3.00009-2
In Vitro and In Vivo Studies on Antibodies - N-terminally Truncated Abeta in the 5XFAD Mouse Model
Richard, B. C. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5098
Carter, A. B. (2017) · D-Scholarship@Pitt (University of Pittsburgh)
Masters, C. L., & Beyreuther, K. T. (2001) · Research and perspectives in Alzheimer's disease · doi:10.1007/978-3-662-04399-8_1
Mechanisms of Memory Deficits in Mouse Models of Alzheimer's Disease
Yiu, A. P. (2012) · TSpace (University of Toronto)
Chung, J.-Y. (2015) · ERA: Education and Research Archive (University of Alberta) · doi:10.7939/r32h3s
Dawson, R. (2019) · Research Explorer (The University of Manchester)
Investigating the role of normal and abnormal beta-amyloid processing in cognition
Freeman, T. J. (2019) · ORCA Online Research @Cardiff (Cardiff University)
Recombinant AAV Gene Therapy and Delivery
Carty, N. (2009) · Digital Commons - University of South Florida (University of South Florida)
Genomics of Alzheimer’s disease
Rosenberg, R. N., Lambracht‐Washington, D., Yu, G., & Xia, W. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813866-3.00001-1
Synaptosomal bioenergetic defects in Alzheimer's disease
Adami, P. V. M., & Morelli, L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-815868-5.00030-x
Abbas, T. F. (2014) · Iraqi Journal of Science
Koch, B. M. E. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7716
Les amyloïdoses : détection à l'aide de nanoparticules et propriétés optiques originales
Pansieri, J. (2017) · theses.fr (ABES) · doi:10.70675/0e785fbcz0be7z4c5fz8158zc5e08a3c8269
McKeever, P. M. (2018) · TSpace (University of Toronto)
Glial cells and neuronal function in Alzheimer's disease
Smit, T. (2020) · UvA-DARE (University of Amsterdam)
Amyloid beta resistance and the Warburg effect: Re-examining Alzheimer's disease
Newington, J. T. (2013) · Scholarship@Western (Western University)
Cerebral amyloid angiopathy : new insights from transgenic mice
Herzig, M. C. (2004) · edoc (University of Basel) · doi:10.5451/unibas-003642738
Search for early TTR-related biomarkers in a transgenic AD mouse model
Santos, L. M. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/h957-t073
Etudes biologiques de nouveaux radiotraceurs pour l'imagerie moléculaire de la maladie d'Alzheimer
Garin, D. (2012) · theses.fr (ABES) · doi:10.70675/7261dcecz2ebbz4693z91f3zaa6f8d6ccedb
Tiermodelle in der biomedizinischen Forschung
Strehle, M., & Britisch, S. (2008) · Springer eBooks · doi:10.1007/978-3-540-69414-4_9
Perry, G. L. (2005) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.1024083.286702
Hernandez, A. C. M. (2011) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3555
Anderson, H. S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99471-6
Pedersen, W. A. (2007) · Elsevier eBooks · doi:10.1016/b978-008055232-3.60663-4
Kraft, A. W., & Lee, J. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780199794591.003.0064
Characterization of translational mechanisms in astrocytes
Oudart, M. (2022) · theses.fr (ABES) · doi:10.70675/a57d2251zdcd7z480czb9acz75c51c2a2a15
Ding, B., Lin, C., Liu, Q., He, Y., Ruganzu, J. B., Jin, H. Z., Peng, X., Ji, S., Ma, Y., & Yang, W. (2020) · Figshare · doi:10.6084/m9.figshare.13093892
Metadata
- Authors
- Borchelt, D. R., Ratovitski, T., van Lare, J., Lee, M. K., Gonzales, V., Jenkins, N. A., Copeland, N. G., Price, D. L., & Sisodia, S. S.
- Affiliations
- Johns Hopkins University (US)
- Frederick National Laboratory for Cancer Research (US)
- Corresponding author
- Borchelt, David R
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 1997-10
- Volume
- 19
- Issue
- 4
- Pages
- 939-945
- ISSN
- 0896-6273 (ISSN-L)
- OpenAlex
- W2062214806
- Cited by
- 1,023
- References
- 52
- Citations by year
- 2026: 9 · 2025: 13 · 2024: 16 · 2023: 17 · 2022: 18 · 2021: 36 · 2020: 35 · 2019: 25 · 2018: 30 · 2017: 38 · 2016: 29 · 2015: 38 · 2014: 33 · 2013: 44 · 2012: 46
- FWCI
- 17.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Neuron (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG 14248, P50AG005146, P01AG014248, AG 05146)
- National Institute of Neurological Disorders and Stroke (NS-20471)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- presenilin 1, presenilin 2, amyloid precursor protein, familial Alzheimer's disease, amyloid-beta deposition, transgenic mice, amyloid-beta 42, amyloidosis, Alzheimer's disease pathogenesis
- MeSH terms
- Aging, Alzheimer Disease, Amyloid, Animals, Brain, Family, Humans, Membrane Proteins, Mice, Transgenic, Pedigree, Recombinant Fusion Proteins, Sweden, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Mice, Presenilin-1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review